LAM
WST icon

Lebenthal Asset Management’s West Pharmaceutical WST Stock Holding History

Lebenthal Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-126
Closed -$9K – 693
2016
Q3 		$9K Buy
+126
New +$10K ﹤0.01% 781

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lebenthal Asset Management's WST Position: Q4 2016 in Review

Lebenthal Asset Management sold out of West Pharmaceutical (WST) in Q4 2016, closing a stake of 126 shares — an estimated $9K sold.

Lebenthal Asset Management first reported a position in WST in Q3 2016 and held it in 1 quarter. The position peaked at $9K in Q3 2016. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

  • Lebenthal Asset Management reported no remaining West Pharmaceutical position as of Q4 2016 after selling out during the quarter.
  • Lebenthal Asset Management sold 126 West Pharmaceutical shares in Q4 2016, an estimated $9K.
  • Lebenthal Asset Management first reported a position in West Pharmaceutical in Q3 2016 and held it in 1 quarter.
  • Lebenthal Asset Management's West Pharmaceutical position peaked at $9K in Q3 2016.
  • 288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on Lebenthal Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.